Top Biotechnology companies in United States by Free Cash Flow

This ranking features the top 496 Biotechnology companies in United States ranked by Free Cash Flow, totalling a Free Cash Flow of USD -32.67 B, for January 15, 2025.

United States

Biotechnology

#	Name	Free Cash Flow	Reported Date	Stock Price	Change	Country
1	AbbVie Inc. 1 ABBV	USD 15.62 B	Sept. 30, 2024	USD 175.55	-0.67%	United States
2	Bristol-Myers Squibb Company 2 BMY	USD 13.80 B	Sept. 30, 2024	USD 55.74	0.69%	United States
3	Gilead Sciences, Inc. 3 GILD	USD 9.43 B	Sept. 30, 2024	USD 91.00	1.18%	United States
4	Pfizer Inc. 4 PFE	USD 8.23 B	Sept. 29, 2024	USD 26.41	-1.46%	United States
5	Thermo Fisher Scientific Inc. 5 TMO	USD 7.78 B	Sept. 28, 2024	USD 556.99	0.27%	United States
6	Amgen Inc. 6 AMGN	USD 6.28 B	Sept. 30, 2024	USD 267.10	-1.14%	United States
7	Danaher Corporation 7 DHR	USD 5.01 B	Sept. 27, 2024	USD 237.62	-0.94%	United States
8	Regeneron Pharmaceuticals, Inc. 8 REGN	USD 3.38 B	Sept. 30, 2024	USD 690.87	-3.63%	United States
9	Stryker Corporation 9 SYK	USD 3.21 B	Sept. 30, 2024	USD 362.80	0.50%	United States
10	Zoetis Inc. 10 ZTS	USD 2.31 B	Sept. 30, 2024	USD 164.41	-1.15%	United States
11	IQVIA Holdings Inc. 11 IQV	USD 1.96 B	Sept. 30, 2024	USD 197.96	-3.26%	United States
12	Corteva, Inc. 12 CTVA	USD 1.91 B	Sept. 30, 2024	USD 60.89	1.60%	United States
13	Royalty Pharma plc 13 RPRX	USD 1.80 B	Sept. 30, 2024	USD 30.03	0.13%	United States
14	Biogen Inc. 14 BIIB	USD 1.77 B	Sept. 30, 2024	USD 143.06	-4.74%	United States
15	Agilent Technologies, Inc. 15 A	USD 1.37 B	Oct. 31, 2024	USD 143.43	1.04%	United States
16	United Therapeutics Corporation 16 UTHR	USD 898.10 M	Sept. 30, 2024	USD 364.70	0.50%	United States
17	Laboratory Corporation of America Holdings 17 LH	USD 843.20 M	Sept. 30, 2024	USD 234.50	0.17%	United States
18	Avantor, Inc. 18 AVTR	USD 747.20 M	Sept. 30, 2024	USD 21.72	-1.36%	United States
19	Revvity, Inc. 19 RVTY	USD 564.37 M	Sept. 29, 2024	USD 120.73	-1.61%	United States
20	Charles River Laboratories International, Inc. 20 CRL	USD 560.48 M	Sept. 28, 2024	USD 178.08	-6.34%	United States
21	Illumina, Inc. 21 ILMN	USD 546.00 M	Sept. 29, 2024	USD 136.48	-5.37%	United States
22	DexCom, Inc. 22 DXCM	USD 535.00 M	Sept. 30, 2024	USD 79.17	-0.84%	United States
23	Lantheus Holdings, Inc. 23 LNTH	USD 451.98 M	Sept. 30, 2024	USD 92.62	-2.15%	United States
24	Exelixis, Inc. 24 EXEL	USD 423.19 M	Sept. 27, 2024	USD 35.65	0.99%	United States
25	Halozyme Therapeutics, Inc. 25 HALO	USD 392.71 M	Sept. 30, 2024	USD 53.83	-0.57%	United States
26	BioMarin Pharmaceutical Inc. 26 BMRN	USD 300.88 M	Sept. 30, 2024	USD 63.81	-4.75%	United States
27	Globus Medical, Inc. 27 GMED	USD 293.77 M	Sept. 30, 2024	USD 88.18	1.15%	United States
28	Bio-Techne Corporation 28 TECH	USD 245.03 M	Sept. 30, 2024	USD 74.73	-2.21%	United States
29	Protagonist Therapeutics, Inc. 29 PTGX	USD 229.23 M	Sept. 30, 2024	USD 36.67	-1.26%	United States
30	Bio-Rad Laboratories, Inc. 30 BIO	USD 223.14 M	Sept. 30, 2024	USD 342.23	-2.69%	United States
31	Harmony Biosciences Holdings, Inc. 31 HRMY	USD 220.18 M	Sept. 30, 2024	USD 36.42	-0.08%	United States
32	Fortrea Holdings Inc. 32 FTRE	USD 220.00 M	Sept. 30, 2024	USD 17.64	-3.66%	United States
33	ACADIA Pharmaceuticals Inc. 33 ACAD	USD 202.66 M	Sept. 30, 2024	USD 16.90	-5.59%	United States
34	Pacira BioSciences, Inc. 34 PCRX	USD 193.53 M	Sept. 30, 2024	USD 20.55	-2.74%	United States
35	Catalyst Pharmaceuticals, Inc. 35 CPRX	USD 188.02 M	Sept. 30, 2024	USD 22.19	-0.09%	United States
36	Amphastar Pharmaceuticals, Inc. 36 AMPH	USD 170.15 M	Sept. 30, 2024	USD 38.48	1.48%	United States
37	Balchem Corporation 37 BCPC	USD 162.58 M	Sept. 30, 2024	USD 158.62	1.47%	United States
38	First Advantage Corporation 38 FA	USD 162.10 M	Sept. 30, 2024	USD 17.21	-1.54%	United States
39	Bruker Corporation 39 BRKR	USD 156.70 M	Sept. 30, 2024	USD 61.26	-2.69%	United States
40	Corcept Therapeutics Incorporated 40 CORT	USD 142.60 M	Sept. 30, 2024	USD 51.66	1.18%	United States
41	Emergent BioSolutions Inc. 41 EBS	USD 138.10 M	Sept. 30, 2024	USD 9.36	-0.53%	United States
42	Repligen Corporation 42 RGEN	USD 131.25 M	Sept. 30, 2024	USD 156.55	-1.19%	United States
43	Ironwood Pharmaceuticals, Inc. 43 IRWD	USD 123.82 M	Sept. 30, 2024	USD 3.65	-3.18%	United States
44	Exact Sciences Corporation 44 EXAS	USD 98.43 M	Sept. 30, 2024	USD 54.20	-7.37%	United States
45	Radius Health, Inc. 45 RDUS	USD 93.41 M	Nov. 30, 2023	USD 11.35	-0.53%	United States
46	ADMA Biologics, Inc. 46 ADMA	USD 79.18 M	Sept. 30, 2024	USD 16.32	-1.03%	United States
47	ANI Pharmaceuticals, Inc. 47 ANIP	USD 73.64 M	Sept. 30, 2024	USD 54.16	0.43%	United States
48	Sotera Health Company 48 SHC	USD 71.49 M	Sept. 30, 2024	USD 12.76	-2.52%	United States
49	SIGA Technologies, Inc. 49 SIGA	USD 71.48 M	Sept. 30, 2024	USD 6.33	4.46%	United States
50	OraSure Technologies, Inc. 50 OSUR	USD 64.00 M	Sept. 30, 2024	USD 3.67	-0.81%	United States

1 2 3 4 … 10

Frequently Asked Questions

Which Biotechnology company in United States has the highest Free Cash Flow ?

The Biotechnology company in United States with the highest Free Cash Flow is AbbVie Inc. (NYSE: ABBV) at USD 15.62 B.
Which Biotechnology company in United States has the lowest Free Cash Flow ?

The Biotechnology company in United States with the lowest Free Cash Flow is Inovio Pharmaceuticals, Inc. (NasdaqCM: INO) at USD -84.44 B.

What are the top 10 Biotechnology companies in United States by Free Cash Flow ?

The top 10 Biotechnology companies in United States by Free Cash Flow are AbbVie Inc., Bristol-Myers Squibb Company, Gilead Sciences, Inc., Pfizer Inc., Thermo Fisher Scientific Inc., Amgen Inc., Danaher Corporation, Regeneron Pharmaceuticals, Inc., Stryker Corporation and Zoetis Inc..
What are the bottom 10 Biotechnology companies in United States by Free Cash Flow ?

The bottom 10 Biotechnology companies in United States by Free Cash Flow are Inovio Pharmaceuticals, Inc., Moderna, Inc., Vertex Pharmaceuticals Incorporated, Insmed Incorporated, Vaxcyte, Inc., GRAIL, LLC, Arrowhead Pharmaceuticals, Inc., Revolution Medicines, Inc., Biohaven Pharmaceutical Holding Company Ltd. and Vir Biotechnology, Inc..